Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
The present invention recognizes that medical devices, such as but not limited to contact lenses, can be made having a coating made at least in part using printing technologies to provide drug storage and drug release structures. The coating preferably includes at least one drug reservoir layer and a least one barrier layer, and can include structures, such as but not limited to capillary structures that alone or in combination modulate the release of the drug from the coating. One aspect of the present invention is a medical device that incorporates a drug in at least one coating. A second aspect of the present invention is a method of making a medical device that incorporates a drug in at least one coating. A third aspect of the present invention is a method of using a medical device of the present invention to treat, prevent from having, prevent from developing, control, reduce the severity, or reduce the progression of a disease, disorder or condition of a subject.
1. A medical device, comprising:
a) a contact lens comprising a first surface and a second surface;
b) said contact lens further comprising at least one coating provided on at least a portion of said first surface, said second surface, or a combination thereof as opposed to within said contact lens, wherein said at least one coating comprises at least one drug;
1) said at least one coating comprising at least one three dimensional structure;
2) said at least one three dimensional structure comprising:
a. one or more drug reservoir layers; wherein said one or more drug reservoir layers comprise one or more drugs; and
b. one or more barrier layers;
c) wherein said one or more barrier layers modulate the release of said one or more drugs from said contact lens;
d) wherein said one or more drug reservoir layers, said one or more barrier layers, or a combination thereof, are oriented vertically, horizontally, or a combination thereof, relative to each other;
wherein said one or more drugs can treat, prevent, control, reduce the severity, or reduce the progression of myopia in a subject in need thereof;
further wherein said one or more drugs is released from said contact lens in a pharmaceutically effective amount to treat, prevent, control, reduce the severity, or reduce the progression of myopia in a subject when said medical device is operably engaged with the eye of said subject.
2. The medical device of claim 1 ,
wherein said medical device is provided as part of a system to treat, prevent, control, reduce the severity, or reduce the progression of myopia in a subject.
3. The medical device of claim 2 ,
wherein said system comprises at least one packaging, at least one set of instructions, at least one solution, or a combination thereof.
4. The medical device of claim 1 ,
wherein said one or more drugs comprise atropine.
5. The medical device of claim 4 ,
wherein said atropine is present in a concentration from between about 0.003% and about 5% (W/W basis).
6. The medical device of claim 1 ,
wherein said contact lens comprises a multi-focal contact lens, or non-corrective lens.
7. The medical device of claim 1 ,
wherein said contact lens comprises a bifocal contact lens.
8. The medical device of claim 1 ,
wherein said contact lens comprises an orthokeratology contact lens.
9. The medical device of claim 1 ,
wherein said contact lens comprises a soft contact lens, a hydrogel contact lens, a silicone hydrogel contact lens, a hard contact lens, a gas permeable contact lens, or a combination thereof.
10. The medical device of claim 1 ,
wherein said contact lens comprises a pre-made contact lens or a pre-manufactured contact lens.
11. The medical device of claim 1 ,
wherein said one or more drugs comprise an anti-muscarinic agent, a muscarinic antagonist, a muscarinic receptor antagonist, or a combination thereof.
12. The medical device of claim 1 ,
wherein said one or more drugs comprise atropine, atropine sulphate monohydrate, pirenzepine, racanisodamine, cyclopentolate, homatropine, scopolamine, telenzepine, nuvenzepine, rispenzepine, or a combination thereof.
13. The medical device of claim 1 ,
wherein said one or more drugs comprise atropine, atropine sulphate monohydrate, pirenzepine, or a combination thereof.
14. The medical device of claim 1 ,
wherein said one or more drugs comprise a dopamine agonist.
15. The medical device of claim 1 ,
wherein said one or more drugs comprise apomorphine, bromocriptine, quinpirole, levodopa, or a combination thereof.
16. The medical device of claim 1 ,
wherein said at least one coating is made in whole or in part by printing.
17. The medical device of claim 1 ,
wherein said at least one coating is made in whole or in part by digital printing, 3D printing, digital 3D printing, or a combination thereof.
18. The medical device of claim 1 ,
wherein said at least one coating is made in whole or in part by additive printing, additive 3D printing, or a combination thereof.
19. The medical device of claim 1 ,
wherein said one or more drugs is released from said medical device at a constant rate, a substantially constant rate, or kinetics of any order.
20. The medical device of claim 1 ,
wherein said one or more drugs is released from said medical device intermittently, by sustained release, or a combination thereof.
21. The medical device of claim 1 ,
wherein said one or more drugs comprise at least one comfort enhancing agent.
22. The medical device of claim 1 ,
wherein said at least one coating further comprises at least one comfort enhancing agent within said at least one coating.
23. The medical device of claim 21 ,
wherein said at least one comfort enhancing agent is hyaluronic acid (HA).
24. The medical device of claim 22 ,
wherein said at least one comfort enhancing agent is hyaluronic acid (HA).
25. The medical device of claim 21 ,
further wherein said at least one comfort enhancing agent is provided within said contact lens, on the surface of said contact lens, or a combination thereof.
26. The medical device of claim 22 ,
further wherein said at least one comfort enhancing agent is provided within said contact lens, on the surface of said contact lens, or a combination thereof.
27. The medical device of claim 21 ,
further wherein said at least one comfort enhancing agent is provided on at least one surface of said contact lens by way of at least one coating.
28. The medical device of claim 22 ,
further wherein said at least one comfort enhancing agent is provided on at least one surface of said contact lens by way of at least one coating.